loader
Please Wait
Applying Filters...

Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Approved Drug Products containing 208147 listed in the FDA Orange Book. Original Data : FDA Website

    Client Virtual Booth
    Menu

    Tris Pharma Inc

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 TRIS PHARMA INC (1)

    filter

    01 SUSPENSION, EXTENDED RELEASE;ORAL (1)

    filter

    01 RX (1)

    filter

    01 DYANAVEL XR (1)

    filter

    01 Yes (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us
    Contact Supplier
    • FDA
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    AMPHETAMINE; AMPHETAMINE ASPARTATE/DEXTROAMPHETAMINE SULFATE

    PDF Supplier PDF
    URL Supplier Web Content
    SUSPENSION, EXTEND...
    2MG/ML;EQ 0.5MG BA...
    2015-10-19
    208147
    DYANAVEL XR
    RX
    Yes
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Looking for FDA Orange Book APPLICATION 208147

    Looking for FDA Orange Book APPLICATION 208147 1

    19

    Tris Pharma Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.

    One of their notable products is AMPHETAMINE; AMPHETAMINE ASPARTATE/DEXTROAMPHETAMINE SULFATE, with a corresponding application number 208147.

    Regulatory Information RX

    With a dosage strength 2MG/ML;EQ 0.5MG BASE/ML

    Dosage Form Route SUSPENSION, EXTENDED RELEASE; ORAL

    Reference Listed Drug Yes

    Approved since 2015-10-19

    Post Enquiry
    POST ENQUIRY